Simulation Methods to Inform Study Design and Understand Potential Bias: The Example of Random Error in AD Biomarkers

Abstract

Novel blood-based biomarkers for Alzheimer’s disease pathology are increasingly available and are appealing options for inclusion in population-based studies due to numerous advantages related to cost and low invasiveness. However, they are subject to more random measurement error (i.e.